相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Investigating the effects of two novel 4-MMPB analogs as potent lipoxygenase inhibitors for prostate cancer treatment
Sonia Iranpour et al.
JOURNAL OF BIOLOGICAL RESEARCH-THESSALONIKI (2021)
O-prenylated carbostyrils as a novel class of 15-lipoxygenase inhibitors: Synthesis, characterization, and inhibitory assessment
Seyed Jamal Alavi et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2021)
Discovering the structure-activity relationships of different O-prenylated coumarin derivatives as effective anticancer agents in human cervical cancer cells
Ebrahim H. Maleki et al.
TOXICOLOGY IN VITRO (2020)
Guidelines for cell viability assays
Senem Kamiloglu et al.
FOOD FRONTIERS (2020)
A novel class of human 15-LOX-1 inhibitors based on 3-hydroxycoumarin
Seyed Jamal Alavi et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2018)
The evolutionary hypothesis of reaction specificity of mammalian ALOX15 orthologs
Hartmut Kuhn et al.
PROGRESS IN LIPID RESEARCH (2018)
5-farnesyloxycoumarin: a potent 15-LOX-1 inhibitor, prevents prostate cancer cell growth
Ala Orafaie et al.
MEDICINAL CHEMISTRY RESEARCH (2017)
Synthesis, structure-activity relationships and preliminary mechanism of action of novel water-soluble 4-quinolone-3-carboxamides as antiproliferative agents
Zeyan Zhang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
An overview of quinoline as a privileged scaffold in cancer drug discovery
Robert Musiol
EXPERT OPINION ON DRUG DISCOVERY (2017)
Evaluation of mouse red blood cell and platelet counting with an automated hematology analyzer
Teruko Fukuda et al.
JOURNAL OF VETERINARY MEDICAL SCIENCE (2017)
Increased 15-lipoxygenase-1 expression in chondrocytes contributes to the pathogenesis of osteoarthritis
Kaizhe Chen et al.
CELL DEATH & DISEASE (2017)
Natural Products as Platforms To Overcome Antibiotic Resistance
Sean E. Rossiter et al.
CHEMICAL REVIEWS (2017)
Synthesis and in vitro antitumor activity of novel naphthyridinone derivatives
Xue-Dong Jia et al.
CHINESE CHEMICAL LETTERS (2017)
8-Farnesyloxycoumarin induces apoptosis in PC-3 prostate cancer cells by inhibition of 15-lipoxygenase-1 enzymatic activity
Minoo Hosseinymehr et al.
ANTI-CANCER DRUGS (2016)
PSMA-specific theranostic nanoplex for combination of TRAIL gene and 5-FC prodrug therapy of prostate cancer
Zhihang Chen et al.
BIOMATERIALS (2016)
Temoporfin-loaded 1-tetradecanol-based thermoresponsive solid lipid nanoparticles for photodynamic therapy
Ingrid Brezaniova et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Antimalarial Chemotherapy: Natural Product Inspired Development of Preclinical and Clinical Candidates with Diverse Mechanisms of Action
Elena Fernandez-Alvaro et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
A phase 1 study of the sachet formulation of the oral dual PI3K/mTOR inhibitor BEZ235 given twice daily (BID) in patients with advanced solid tumors
Johanna C. Bendell et al.
INVESTIGATIONAL NEW DRUGS (2015)
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
Christopher J. Sweeney et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Positive and negative effects of glitazones in carcinogenesis: Experimental models vs. clinical practice
Bianka Bojkova et al.
PATHOLOGY RESEARCH AND PRACTICE (2014)
15-Lipoxygenase-1-mediated metabolism of docosahexaenoic acid is required for syndecan-1 signaling and apoptosis in prostate cancer cells
Yunping Hu et al.
CARCINOGENESIS (2013)
Design, synthesis and antitumour activity of bisquinoline derivatives connected by 4-oxy-3-fluoroaniline moiety
Sai Li et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
Synthesis and SAR studies of mono O-prenylated coumarins as potent 15-lipoxygenase inhibitors
Mehrdad Iranshahi et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2012)
15-Lipoxygenase Metabolites of Docosahexaenoic Acid Inhibit Prostate Cancer Cell Proliferation and Survival
Joseph T. O'Flaherty et al.
PLOS ONE (2012)
Relationship between Dietary Factors and Prostate-Specific Antigen in Healthy Men
Kazuhiro Ohwaki et al.
UROLOGIA INTERNATIONALIS (2012)
Mechanistic Contribution of Ubiquitous 15-Lipoxygenase-1 Expression Loss in Cancer Cells to Terminal Cell Differentiation Evasion
Micheline J. Moussalli et al.
CANCER PREVENTION RESEARCH (2011)
Feeder- and serum-free establishment and expansion of human induced pluripotent stem cells
Mehdi Totonchi et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY (2010)
15-Lipoxygenases and its metabolites 15(S)-HETE and 13(S)-HODE in the development of non-small cell lung cancer
Huiling Yuan et al.
THORAX (2010)
Peroxisome proliferator-activated receptor gamma in human prostate carcinoma
Yasuhiro Nakamura et al.
PATHOLOGY INTERNATIONAL (2009)
Prostate Tumor Growth Can Be Modulated by Dietarily Targeting the 15-Lipoxygenase-1 and Cyclooxygenase-2 Enzymes
Uddhav P. Kelavkar et al.
NEOPLASIA (2009)
Kinetics of soybean lipoxygenases are related to pH, substrate availability and extraction procedures
Veronica S. Chedea et al.
JOURNAL OF FOOD BIOCHEMISTRY (2008)
Peroxisome proliferator-activated receptor γ-independent suppression of androgen receptor expression by troglitazone mechanism and pharmacologic exploitation
Chih-Cheng Yang et al.
CANCER RESEARCH (2007)
DNA methylation paradigm shift: 15-Lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation
U. P. Kelavkar et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2007)
Identification of 12/15-lipoxygenase as a suppressor of myeloproliferative disease
Melissa Kristine Middleton et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
15-lipoxygenase-2 gene regulation by its product 15-(S)-hydroxyeicosatetraenoic acid through a negative feedback mechanism that involves peroxisome proliferator-activated receptor γ
V. Subbarayan et al.
ONCOGENE (2006)
Reduction of isoforms of 15-lipoxygenase (15-LOX)-1 and 15-LOX-2 in human breast cancer
WG Jiang et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2006)
被撤回的出版物: RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo (Retracted article. See vol. 295, pg. 13136, 2020)
SM Pulukuri et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The PPAR-γ agonist pioglitazone post-transcriptionally induces p21 in PC3 prostate cancer but not in other cell lines
SK Radhakrishnan et al.
CELL CYCLE (2005)
Inverse relationship between 15-lipoxygenase-2 and PPAR-γ gene expression in normal epithelia compared with tumor epithelia
V Subbarayan et al.
NEOPLASIA (2005)
Bacterial topolsomerase inhibitors: Quinolone and pyridone antibacterial agents
LA Mitscher
CHEMICAL REVIEWS (2005)
Macronutrients, fatty acids, cholesterol and prostate cancer risk
E Bidoli et al.
ANNALS OF ONCOLOGY (2005)
Up-regulation of p21 gene expression by peroxisome proliferator-activated receptor γ in human lung carcinoma cells
SW Han et al.
CLINICAL CANCER RESEARCH (2004)
Primary culture model of peroxisome proliferator-activated receptor γ activity in prostate cancer cells
Y Xu et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2003)
Opposing effects of 15-lipoxygenase-1 and-2 metabolites on MAPK signaling in prostate -: Alteration in peroxisome proliferator-activated receptor γ
LC Hsi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Overexpression of 15-lipoxygenase-1 in PC-3 human prostate cancer cells increases tumorigenesis
UP Kelavkar et al.
CARCINOGENESIS (2001)
Expression of 15-lipoxygenase-1 is regulated by histone acetylation in human colorectal carcinoma
H Kamitani et al.
CARCINOGENESIS (2001)
分享论文
